默沙东92亿美元收购Cidara Therapeutics推动流感预防领域发展

默沙东宣布以每股221.5美元现金收购Cidara Therapeutics，交易总价值约92亿美元，预计2026年第一季度完成。此次收购旨在获得Cidara的长效流感抗体药物，推动流感预防领域发展。

相关股票

相关资讯

获默沙东(MRK.US)92亿美元收购 Cidara (CDTX.US)股价盘前翻番

智通财经·2025/11/14

获默沙东(MRK.US)92亿美元收购 Cidara (CDTX.US)股价盘前翻番

默沙东以每股221.5美元现金收购Cidara Therapeutics

智通财经网·2025/11/14

默沙东以每股221.5美元现金收购Cidara Therapeutics

Cidara Therapeutics 股价继续上涨，盘前上涨104%，因默克同意以约92亿美元收购该公司

美股速递·2025/11/14

Cidara Therapeutics 股价继续上涨，盘前上涨104%，因默克同意以约92亿美元收购该公司

默克将以92亿美元收购Cidara Therapeutics

MT Newswires Live·2025/11/14

默克将以92亿美元收购Cidara Therapeutics

默沙东拟收购Cidara Therapeutics, Inc.，多元化其投资组合，增添晚期抗病毒药物

美股速递·2025/11/14

默沙东拟收购Cidara Therapeutics, Inc.，多元化其投资组合，增添晚期抗病毒药物

默沙东：根据并购协议，默沙东通过其子公司将收购Cidara的所有流通股

美股速递·2025/11/14

默沙东：根据并购协议，默沙东通过其子公司将收购Cidara的所有流通股

默克药厂将以每股221.50美元现金收购Cidara Therapeutics公司。

智通财经·2025/11/14

默克药厂将以每股221.50美元现金收购Cidara Therapeutics公司。

Cidara Therapeutics美股盘前涨幅扩大至105%默沙东将以每股221.5美元现金收购公司预计交易将于20

智通财经·2025/11/14

Cidara Therapeutics美股盘前涨幅扩大至105%默沙东将以每股221.5美元现金收购公司预计交易将于20

热议股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/economy/e0d7686fa8386219791330d46be969bf"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"__swrFallback__":{"@#url:\"https://community-service.laohu8.com/v1/financial/theme/news\",params:#themeId:\"e0d7686fa8386219791330d46be969bf\",region:\"SGP\",,,undefined,":{"bottom":false,"list":[{"cardType":"NEWS","cardId":"NEWS.2583503987","cardData":[{"id":"2583503987","pubTimestamp":1763122227,"title":"获默沙东(MRK.US)92亿美元收购 Cidara (CDTX.US)股价盘前翻番","summary":"","media":"智通财经","labels":[],"importantFlag":0,"likeCount":0,"liked":false,"publishNews":false,"publishLive":true}],"position":0},{"cardType":"NEWS","cardId":"NEWS.1179242353","cardData":[{"id":"1179242353","pubTimestamp":1763121961,"title":"默沙东以每股221.5美元现金收购Cidara Therapeutics","summary":"","media":"智通财经网","labels":["movement"],"importantFlag":0,"likeCount":0,"liked":false,"publishNews":true,"publishLive":true,"news_tag":"movement"}],"position":0},{"cardType":"NEWS","cardId":"NEWS.1163990293","cardData":[{"id":"1163990293","pubTimestamp":1763121511,"title":"Cidara Therapeutics 股价继续上涨，盘前上涨104%，因默克同意以约92亿美元收购该公司","summary":"","media":"美股速递","labels":["corporation","merge"],"importantFlag":0,"likeCount":0,"liked":false,"publishNews":true,"publishLive":true,"news_tag":"corporation,merge"}],"position":0},{"cardType":"NEWS","cardId":"NEWS.2583085945","cardData":[{"id":"2583085945","pubTimestamp":1763120939,"title":"默克将以92亿美元收购Cidara Therapeutics","summary":"","media":"MT Newswires Live","labels":["corporation"],"importantFlag":0,"likeCount":0,"liked":false,"publishNews":true,"publishLive":false,"news_tag":"corporation"}],"position":0},{"cardType":"NEWS","cardId":"NEWS.1132885105","cardData":[{"id":"1132885105","pubTimestamp":1763120836,"title":"默沙东拟收购Cidara Therapeutics, Inc.，多元化其投资组合，增添晚期抗病毒药物","summary":"","media":"美股速递","labels":["corporation","merge"],"importantFlag":0,"likeCount":0,"liked":false,"publishNews":true,"publishLive":true,"news_tag":"corporation,merge"}],"position":0},{"cardType":"NEWS","cardId":"NEWS.1179739827","cardData":[{"id":"1179739827","pubTimestamp":1763120835,"title":"默沙东：根据并购协议，默沙东通过其子公司将收购Cidara的所有流通股","summary":"","media":"美股速递","labels":["corporation","merge"],"importantFlag":0,"likeCount":0,"liked":false,"publishNews":true,"publishLive":true,"news_tag":"corporation,merge"}],"position":0},{"cardType":"NEWS","cardId":"NEWS.2583560508","cardData":[{"id":"2583560508","pubTimestamp":1763120831,"title":"默克药厂将以每股221.50美元现金收购Cidara Therapeutics公司。","summary":"","media":"智通财经","labels":[],"importantFlag":0,"likeCount":0,"liked":false,"publishNews":false,"publishLive":true}],"position":0},{"cardType":"NEWS","cardId":"NEWS.2583508934","cardData":[{"id":"2583508934","pubTimestamp":1763120820,"title":"Cidara Therapeutics美股盘前涨幅扩大至105%默沙东将以每股221.5美元现金收购公司预计交易将于20","summary":"","media":"智通财经","labels":[],"importantFlag":0,"likeCount":0,"liked":false,"publishNews":false,"publishLive":true}],"position":0}],"size":8,"extra":{"requestId":"d09831fad886446cbbf4b1be2f27acc1"}},"@#url:\"https://community-service.laohu8.com/v1/theme/info\",params:#region:\"SGP\",,method:\"POST\",data:#themeId:\"e0d7686fa8386219791330d46be969bf\",,,undefined,":{"themeId":"e0d7686fa8386219791330d46be969bf","name":"默沙东92亿美元收购Cidara Therapeutics推动流感预防领域发展","description":"默沙东宣布以每股221.5美元现金收购Cidara Therapeutics，交易总价值约92亿美元，预计2026年第一季度完成。此次收购旨在获得Cidara的长效流感抗体药物，推动流感预防领域发展。","image":"https://static.tigerbbs.com/835661b76c0e2779b1add4e61f930749","type":2,"style":4,"follow":false,"createTime":1763131637866,"userCounts":0,"rnLink":"https://laohu8.com/RN?name=RNTheme&page=/theme/special/finance&rndata={\"themeId\":e0d7686fa8386219791330d46be969bf}&rnconfig={\"headerBarHidden\": true}","subscribe":false,"allowFollow":false,"hasReward":false,"rewardScore":0,"rewardValidDate":0,"rewardEnd":false,"symbols":["MRK","CDTX"],"tweetCounts":0,"categoryId":"2929bb7468f5415f853fd96fb35d7c3b","options":[],"votedOptionId":"","totalUserCount":0,"followStatus":false,"themeName":"默沙东92亿美元收购Cidara Therapeutics推动流感预防领域发展","tweetAmount":0,"imageIsDefault":false,"aiDerivativeIssues":[]}}}